Nrx pharmaceuticals, inc. (nasdaq:nrxp) announces the appointment of michael taylor to its board of directors and appointment of anita nunes as board observer; ms. nunes to be appointed director of hope therapeutics, inc.

Wilmington, del. , jan. 15, 2025 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, and hope therapeutics, inc., a development stage medical and technology driven company and wholly owned subsidiary of nrx, today announced the appointment of mr.
NRXP Ratings Summary
NRXP Quant Ranking